If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Corrigendum to ‘Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis’ International Journal of Infectious Diseases, Volume 119, June 2022, Page 130-139
Division of Pediatric Cardiology, Department of Pediatrics, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, KoreaDepartment of Pediatrics, Yonsei University College of Medicine, Seoul, Korea
Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South KoreaDepartment of Data Science, Sejong University College of Software Convergence, Seoul, South Korea
More than 233 million people have been infected with SARS-CoV-2, and 4.7 million people have died of the disease worldwide (as of 1 October 2021). Several vaccines have been developed concerning this public health problem, and 6.2 billion doses have already been administered (COVID-19 Map - Johns Hopkins Coronavirus Resource Center, October 1, 2021). A phase-III clinical trial of the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine included 12,021 participants from the United Kingdom, Brazil, and South Africa, and reported no adverse events related to unusual thrombotic events (Voysey et al., 2021).